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【Abstract】Objective:    To study the expression
changes of matrix metalloproteinases (MMPs) in traumatic
deep vein thrombosis (TDVT) in a rat model with the aid of
gene chip technology and to explore the roles of MMPs in
TDVT.
Methods:    Totally 150 Sprague Dawley rats were ran-
domly divided into control group (n=10) and model group
(n=140). Rat models of TDVT were established by clamping
the femoral vein and fixing the bilateral hind limbs. Then
fixation of the hip spica with plaster bandage was conducted.
According to the observation phases and/or biological situ-
ations of the femoral vein thrombosis, the model rats were
further divided into 7 groups. Vascular tissues were ob-
tained from each group through noninvasive incision into
the femoral vein at corresponding time points. We adopted
the Trizol one-step method for total RNA extraction,
Affymetrix RAT 230 2.0 array for detection of RNA expressions
and fold change (FC) analysis for changes of differential
expressions of MMPs in each group. The main outcome
parameters measured included expressions of MMP-2,
MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-11,
MMP-12, MMP-13, MMP-14, MMP-16, MMP-23 and MMP-
24. Gene array data of these MMPs were analyzed by the
Affymetrix Microarray Analysis software (Version 5.0).
Results:    FC analysis showed differential expressions
of MMPs in each group during the course of TDVT. At the
initial period of thrombosis, MMP-2, MMP-3, MMP-7,
MMP-8, MMP-9, MMP-10, MMP-11, and MMP-24 had sig-
nificantly high expression, while MMP-12, MMP-13,
MMP-14, MMP-16 and MMP-23 had relatively low
expression. MMPs were all highly expressed at the peak
time of thrombosis. In the process of thrombus resolution,
MMP-2, MMP-10, MMP-16 and MMP-24 have relatively
low expression, while MMP-12, MMP-13, MMP-14,
MMP-16 and MMP-23 have significantly high expression.
Conclusion:    MMPs may affect the process of TDVT
through transcription regulation of the fibrinolysis-anti-fi-
brinolytic system during the course of thrombosis and throm-
bus resolution.
Key words:    Rats; Wounds and injuries; Venous
thrombosis; Genes; Matrix metalloproteinases
Traumatic deep vein thrombosis (TDVT) refers todeep vein thrombosis resulting from trauma oroperation. It is common and can bring about
multiple complications such as phlegmasia cerulean
dolens that requires limb amputation and life-threaten-
ing pulmonary thromboembolism. Studies at cellular
and molecular levels reveal that local cells change after
trauma and generate corresponding expression prod-
ucts that further change cell function and transmit mes-
sages around according to increased, decreased, acti-
vated or unactivated gene expressions. Previous stud-
ies have shown that TDVT is a complex disease with
multiple factors, genes and systems involved in.1,2 Ma-
trix metallo-proteinases (MMPs), which result in ex-
cessive degradation of the endothelial basement
membrane, are one of the main factors that affect throm-
bosis and thrombus resolution and the mechanisms
have become a hotspot in recent years.
METHODS
Animals
 This study was approved by the local animal ex-
perimentation and ethics committee. A total of 150
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Sprague Dawley (SD) rats, specific pathogen free, 8-
12 weeks old, weighing 250-300 g, were purchased from
the Animal Center of Kunming Medical College [License:
SCXK (Yunnan) 2005-0008].
Establishment of TDVT rat models3
The 150 SD rats were randomly divided into normal
control group (Group A, n=10) and model group (n=140).
The model rats were anesthetized with 3% pentobar-
bital sodium for 1 mg/kg. Their bilateral thighs were
depilated. Along the longitudinal axis of the thigh, an
about 2 cm-long incision was made on each side to
expose the femoral vein. Each femoral vein was clamped
in three different positions within 3 seconds by 12# mos-
quito forceps. Then, the incision was stitched and rats
were fixed with hip spica cast. After completion of the
modeling, these rats had access to water and grain.
Antibiotics were not used.
Grouping
According to different observation phases and bio-
logical situations of the femoral vein thrombosis, model
rats were further divided into 7 subgroups: Group B (0.5
hour after trauma, the initial period of thrombosis), Group
C (2.5 hours after trauma, the peak time of thrombosis),
Group D (25 hours after trauma, thrombus at peak time),
Group E (25 hours after trauma, no thrombus at peak
time), Group F (72 hours after trauma, thrombus
resolution), Group G (72 hours after trauma, thrombus
insolubilization) and Group H (168 hours after trauma,
non-thrombosis, Figure 1). At each corresponding phase,
every 10 rats with the particular pathological features were
selected into model groups through gross observation.
Materials
At each corresponding time point, vascular tissues
about 2 cm-long from the bilateral femoral vein of each
group were obtained and flushed with 0.9% normal sa-
line to remove blood and intraluminal thrombosis. Then
the tissues were frozen in freezing tubes within 30 sec-
onds in vitro and preserved in liquid nitrogen canisters
for total RNA extraction.
RNA extraction, chip hybridization and scanning
The total RNA was extracted using the Trizol one-
step method and preserved at -80°C after its quality
and quantity had been confirmed by agarose gel elec-
trophoresis (AGE) and spectrophotometer testing. Then
the valid RNA samples were sent to Shanghai Biochip
Co. Ltd (Shanghai, China) within 48 hours where biotin
labeling for hybridization was done.
Data analysis of gene array
Data of the gene array were analyzed by the
Affymetrix Microarray Analysis software (Version 5.0,
Shanghai Biochip Co. Ltd, Shanghai, China). Through
fold change (FC) analysis, we established the selec-
tion standards of differentially expressed genes as
follows: for up-regulation, log2  ratio=1 and change was
marked as I; for down-regulation, log2  ratio=-1 and
change was marked as D. After combination of FC
analysis, we could screen out differentially expressed
genes in each model group. The main parameters to
evaluate outcomes in this study were the expressions of
MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10,
MMP-11, MMP-12, MMP-13, MMP-14, MMP-16, MMP-23
and MMP-24 at different critical time points of TDVT.
RESULTS
Animal model and grouping
Totally two rats died due to excessive bleeding, one
died from unknown causes and the others survived. In
this model, the femoral vein thrombogenesis started at
2.5 hours after trauma. At 25 hours after trauma, the
rate of thrombogenesis reached 50.5% and non-
thrombogenesis was 49.5%. At 168 hours after trauma,
the rate of thrombus resolution was 56.7% and 43.3%
of thrombus constantly did not dissolve.
RNA extraction and electrophoretogram of RNA
samples
Total RNA of vascular tissues of the femoral vein
from each group was extracted by the one-step Trizol
method. AGE analysis showed that the two strands of
28S RNA and 18S RNA were clear. This confirmed that
the RNA samples were in good integrity, high quality
and had no degradation (Figure 2).
Differential expression genes at different phases
As shown in Table 1, genes of the experimental
groups  had differential expressions at different time
points. Compared with normal control group, the num-
ber of up-regulated genes was much larger than that of
down-regulated ones in model group according to FC
analysis. This suggested that the change of local micro-
environment was an important factor that affected throm-
bosis and thrombus resolution in TDVT.
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MMPs expressions
Gene chip detection showed that MMP-2, MMP-3,
MMP-7, MMP-8, MMP-9, MMP-10, MMP-11, MMP-12,
MMP-13, MMP-14, MMP-16, MMP-23, and MMP-24
in TDVT at each time point had different levels of ex-
pression (Table 2 and Figure 3).
FC analysis
Figures 4-6 show that MMP-2, MMP-3, MMP-7,
MMP-8, MMP-9, MMP-10, MMP-11, MMP-12, MMP-13,
MMP-14, MMP-16, MMP-23, and MMP-24 in TDVT had
different levels of expressions at different time points.
Table 1. Frequency of differential expression genes at different phases
 Genes                              BvsA                   CvsA                   DvsA                HvsA                  EvsA                    FvsA                GvsA
Up-regulated genes
Down-regulated genes
Total
214       1386             945                1685 1222        1536           1235
135       1007             798                1105   691        1029             614
349       2393           1743                2790 1913        2565           1849
Table 2. MMPs expressions in TDVT at each time point (n=10 for each group).
Groups
Genes
MMP-2    MMP-3    MMP-7    MMP-8    MMP-9    MMP-10    MMP-11    MMP-12    MMP-13    MMP-14    MMP-16    MMP-23    MMP-24
109.2
133.5
119.4
149.0
118.3
  98.3
102.3
  98.1
A
B
C
D
E
F
G
H
181.6
174.1
315.5
272.2
123.8
112.5
229.1
260.7
100.7
634.4
1167.9
2140.3
    54.1
464.8
1087.8
291.0
  7.5
  4.4
12.3
16.2
  4.6
  9.4
15.9
14.2
114.0
280.9
547.1
452.6
  50.6
201.3
121.7
  93.7
  61.7
  92.8
220.8
233.0
    8.4
  86.8
  88.3
  70.4
  14.1
  23.4
  19.1
  34.9
  10.9
  17.3
  27.3
  22.0
  34.4
  79.0
  95.6
  52.8
127.3
  41.4
140.4
  29.4
  113.5
  116.6
1398.7
  606.0
  117.2
  200.1
  480.7
  162.2
    53.0
    48.0
1363.7
1545.8
    12.6
  355.9
  498.7
    24.7
1313.8
  958.8
7980.9
6935.8
1076.6
4486.1
6326.8
2968.1
  88.2
  47.8
  90.9
  67.9
412.6
  75.8
131.0
117.4
836.7
748.8
968.6
766.7
130.0
794.1
889.1
855.9
Figure 1. Block diagram of control group and model groups.
Figure 3. MMPs had different expressions in TDVT at each time
point.
Figure 2. AGE analysis showed that the strands of 28S RNA, the
thicker band, and 18S RNA, the thinner one, were clear, verifying
that the RNA samples had good integrity, high quality and no
degradation. Figure 4. Changes of MMP expressions in BvsA during the for-
mation of traumatic deep vein thrombus.
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DISCUSSION
Multiple genes are often activated by traumas of
body tissues. These genes, as an important compo-
nent of cell response and regulatory elements, further
activate multiple signal transduction pathways and bring
about corresponding changes. Some of them play the
role of protection or repair, and some could lead to cell
apoptosis or necrosis. MMPs, which stimulate a cas-
cade reaction of gene activation at different time points,
play an important role in the process of TDVT.
Structural and biochemical characteristics of MMPs
MMPs are a family of Zn2+-dependent endopep-
tidase, and also the major media involved in degrada-
tion and remodeling of the extracellular matrix (ECM).
They participate in many physiological and pathologi-
cal processes of human bodies,4,5 and are widely ex-
pressed in vivo.6 In 1962, Wu and Eyre7 found the first
MMP (MMP-1). To date, nearly 30 species have been
found, including 26 already identified and sequenced.
MMPs are secreted in the form of zymogen, activated
after protein hydrolysis and inhibited by some specific
tissue inhibitors of metalloproteinase (TIMPs) and eth-
ylene diamine tetraacetic acid.8,9 The activated MMPs
further promote the plasminogen activation through posi-
tive feedback, thus arousing an activation cascade
reaction.10 The extracellular activated MMPs could de-
grade all the extracellular matrix components except
polysaccharide, and participate in the physiological pro-
cesses of growth and tissue repair.11
MMPs in regulating thrombosis and thrombus resolution
Studies show that activities of matrix degradation
markedly increase with the increased expressions of
MMPs.12 It has been reported that MMP-2 and MMP-9
are involved in the regulation of vascular wall modeling
and migration of collagen and matrix during early wound
repair.13 Visse et al14 confirmed that MMP-2 and MMP-9
are closely related to neovascularization and activity of
proteins converted from collagen fibers in the process
of thrombolysis. This might due to that the expressions
of MMP-2 and MMP-9 have been activated by the uroki-
nase-type plasminogen activator (u-PA).
In this experiment, gene chip test found that MMP-2,
MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-11
and MMP-24 had significantly high expression, while
MMP-12, MMP-13, MMP-14, MMP-16 and MMP-23 had
relatively low expression at the initial period of
thrombosis. This shows that the majority of MMPs are
activated immediately and thus have persistent high
expression due to posttraumatic systemic inflamma-
tory response. However, a small number of MMPs are
at an inhibited state and thus show a low expression.
In this study, MMP-2, MMP-3, MMP-7, MMP-8,
MMP-9, MMP-10, MMP-11, MMP-12, MMP-13, MMP-14,
MMP-16, MMP-23 and MMP-24 were all highly ex-
pressed at the peak time of thrombosis. The mecha-
nism may be that these genes promote the prolifera-
tion of vascular smooth muscle cells, which leads to
narrowness of the blood vessels and further promotes
the formation of traumatic deep vein thrombus.
In the process of thrombus resolution, MMP-2,
MMP-10, MMP-16, and MMP-24 have relatively low
expressions, while MMP-12, MMP-13, MMP-14,
MMP-16 and MMP-23 have signif icantly high
expressions, showing that different MMPs could play
different roles in the resolution of TDVT. The mecha-
nism is that the u-PA receptor located on the surface of
endothelial cells shows biological activity after com-
bined with u-PA and converts single chain urokinase-
type plasminogen activator (scu-PA) into two chain
urokinase-type plasminogen activator (tcu-PA), and
converts plasminogens into activated fibrinolytic en-
zymes to positively regulate thrombolysis.15-18 Moreover,
Figure 5. Changes of MMP expressions in CvsA during the
formation of traumatic deep vein thrombus.
Figure 6. Changes of MMP expressions in EvsA during the reso-
lution of traumatic deep vein thrombus.
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u-PA further activates the majority of MMPs. These ac-
tivated MMPs then facilitate the activation of their zy-
mogens by positive feedback and thus start an activa-
tion cascade reaction. Furthermore, they promote the
migration and proliferation of endothelial cells, smooth
muscle cells, fibroblasts, neointimas and new blood
vessels and  promote thrombous resolution in the end.
This is in accordance with reports in the literatue.19-21
In conclusion, this experiment revealed that MMPs
might play important roles in TDVT. MMPs are acti-
vated during the course of thrombosis, and then they
promot the activation of plasminogens through positive
feedback and further start an activation cascade
reaction. In the course of thrombus resolution, most
MMPs continue to show high expressions, indicating
that they may also play a positive role in repair.
Therefore, MMPs may be one of the most important
factors that influence the biological states of TDVT, but
its mechanisms still need further studies.
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